Severe Acute Respiratory Syndrome

Q&A: Minks Can Transmit SARS-CoV-2 to Humans, Study Shows    The Scientist

Enhancing host cell infection by SARS-CoV-2    Science Magazine

Safety and efficacy of inhaled nebulised interferon beta-1a (SNG001) for treatment of SARS-CoV-2 infection: a randomised, double-blind, placebo-controlled, phase 2 trial    The Lancet

"Cat's claw" extract inhibits replication of SARS-CoV-2 in vitro    News-Medical.Net

SARS-CoV-2 Transmission among Marine Recruits during Quarantine | NEJM    nejm.org

Nafamostat mesylate initially reduces SARS-CoV-2 viral loads in hamsters, study finds    News-Medical.Net

COVID-19 Reinfection and You    UPJ Athletics

An Outbreak of Covid-19 on an Aircraft Carrier | NEJM    nejm.org

Characteristics and outcomes of neonatal SARS-CoV-2 infection in the UK: a prospective national cohort study using active surveillance    The Lancet

Interim Analysis Suggests SARS-CoV-2 Vaccine Has 90% Efficacy Rate    Technology Networks

Promising yeast-expressed SARS-CoV-2 vaccine candidate effective in mice    News-Medical.Net

Cats shed SARS-CoV-2 RNA for a shorter duration compared to humans, study finds    News-Medical.Net

Decreasing humidity in the winter is likely to lead to more COVID-19 cases    News-Medical.Net

SARS-CoV-2 survives for 9 hours on human skin    Healio

Case study details leukemia patient who shed infectious SARS-CoV-2 for at least 70 days    Science Daily

Hydroxychloroquine in the prevention of COVID-19 mortality    The Lancet

Seven Ways to Fix This Pandemic -- and Stop the Next One    Medscape

Challenges in creating herd immunity to SARS-CoV-2 infection by mass vaccination    The Lancet

COVID-19 lung damage caused by persistence of 'abnormal cells'    Science Daily

Persistence of viral RNA, pneumocyte syncytia and thrombosis are hallmarks of advanced COVID-19 pathology    The Lancet